| dc.contributor.author | Brown, Gordon T. | |
| dc.contributor.author | Cash, Beatriz | |
| dc.contributor.author | Alnabulsi, Ayham | |
| dc.contributor.author | Samuel, Leslie M. | |
| dc.contributor.author | Murray, Graeme I. | |
| dc.date.accessioned | 2017-03-02T00:30:41Z | |
| dc.date.available | 2017-03-02T00:30:41Z | |
| dc.date.issued | 2016-03 | |
| dc.identifier.citation | Brown , G T , Cash , B , Alnabulsi , A , Samuel , L M & Murray , G I 2016 , ' The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy ' , Histopathology , vol. 68 , no. 4 , pp. 556-566 . https://doi.org/10.1111/his.12780 | en |
| dc.identifier.issn | 0309-0167 | |
| dc.identifier.other | PURE: 57922502 | |
| dc.identifier.other | PURE UUID: c78601f1-4eb0-46b7-9b7c-36b106a24c2a | |
| dc.identifier.other | PubMed: 26183150 | |
| dc.identifier.other | Scopus: 84957943480 | |
| dc.identifier.other | ORCID: /0000-0002-8402-8670/work/50559791 | |
| dc.identifier.other | ORCID: /0000-0003-3981-2420/work/76973596 | |
| dc.identifier.uri | http://hdl.handle.net/2164/8258 | |
| dc.description | Acknowledgements This study was supported by funding from the Encompass kick start and SMART:Scotland award schemes of Scottish Enterprise and Friends of Anchor. The Grampian Biorepository assisted with the immunohistochemical investigations. | en |
| dc.format.extent | 11 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Histopathology | en |
| dc.rights | This is the peer reviewed version of the following article:Brown G T, Cash B, Alnabulsi A, Samuel L M & Murray G I (2016) Histopathology 68, 556–566. The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy, which has been published in final form at DOI: 10.1111/his.12780. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | bcl-2-associated transcription factor 1 | en |
| dc.subject | biomarker | en |
| dc.subject | immunohistochemistry | en |
| dc.subject | monoclonal antibody | en |
| dc.subject | neoadjuvant therapy | en |
| dc.subject | prognosis | en |
| dc.subject | rectal cancer | en |
| dc.subject | QH301 Biology | en |
| dc.subject.lcc | QH301 | en |
| dc.title | The expression and prognostic significance of bcl-2-associated transcription factor 1 in rectal cancer following neoadjuvant therapy | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Biological Sciences | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Postprint | en |
| dc.identifier.doi | https://doi.org/10.1111/his.12780 | |
| dc.date.embargoedUntil | 2017-03-01 | |
| dc.identifier.vol | 68 | en |
| dc.identifier.iss | 4 | en |
